Lilly and Novo Are Reportedly Near a Deal, Offering $149 GLP-1s in Return for Coverage in Medicare
Shares:
I don’t think there is a whole lot of analysis needed on the Commonwealth Fund’s look at the impact of high health care costs on consumers. A majority of the
Lord, this is lousy. The New York Times is out with an explainer on why the United States has high drug prices. To the extent that there are myths around
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv